Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules - Summary - MDSpire

Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules

  • By

  • Renate Dinnessen

  • Dré Peeters

  • Noa Antonissen

  • Firdaus A. A. Mohamed Hoesein

  • Hester A. Gietema

  • Ernst Th. Scholten

  • Cornelia Schaefer-Prokop

  • Colin Jacobs

  • July 15, 2025

  • 0 min

Share

Objective:

Emphasize the significance of comparing the DL model to the Brock model.

Key Findings:
  • Quantify performance metrics for clarity.
Interpretation:

Elaborate on how the model could specifically reduce healthcare costs.

Limitations:
  • Include potential biases in the data collection process.
Conclusion:

Reiterate the implications for clinical practice.

Original Source(s)

Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules

  • by Renate Dinnessen, Dré Peeters, Noa Antonissen, Firdaus A. A. Mohamed Hoesein, Hester A. Gietema, Ernst Th. Scholten, Cornelia Schaefer-Prokop, Colin Jacobs

  • July 15, 2025

Related Content

Multi-chamber three-dimensional myocardial strain assessment by computed tomography: a comparison with speckle tracking echocardiography and association with pulmonary hypertension in severe aortic stenosis

Early Enteral Feeding Tied to Fewer Complications

Benefit driven by fewer infections and pulmonary events, though overall complication rates were similar

A case report and literature review on imaging manifestations of immature teratoma in fetal oral cavity with concurrent intracranial abnormalities